Skip to main content

Published locations for ICYMI: Andexanet alfa reduces anti–factor Xa activity from apixaban, rivaroxaban

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ICYMI: Andexanet alfa reduces anti–factor Xa activity from apixaban, rivaroxaban

User login

  • Reset your password
  • /content/icymi-andexanet-alfa-reduces-anti-factor-xa-activity-apixaban-rivaroxaban
  • /hematologynews/article/194649/venous-thromboembolism/icymi-andexanet-alfa-reduces-anti-factor-xa
  • /neurologyreviews/article/194649/venous-thromboembolism/icymi-andexanet-alfa-reduces-anti-factor-xa
  • /vascularspecialistonline/article/194649/venous-thromboembolism/icymi-andexanet-alfa-reduces-anti
  • /hematology-oncology/article/194649/venous-thromboembolism/icymi-andexanet-alfa-reduces-anti-factor
  • /ecardiologynews/article/194649/venous-thromboembolism/icymi-andexanet-alfa-reduces-anti-factor-xa
  • /cardiology/article/194649/venous-thromboembolism/icymi-andexanet-alfa-reduces-anti-factor-xa
  • /neurology/article/194649/venous-thromboembolism/icymi-andexanet-alfa-reduces-anti-factor-xa-activity
  • /emergencymedicine/article/194649/venous-thromboembolism/icymi-andexanet-alfa-reduces-anti-factor-xa
  • /clinicalneurologynews/article/194649/venous-thromboembolism/icymi-andexanet-alfa-reduces-anti-factor